Author

Alethia Dixon

University of Michigan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Ahmed Abdel‐LatifiD· 1 shared Anand Singh· 1 shared Charles A. StewardiD· 1 shared Jessica Sim· 1 shared Keith Louis SaumiD· 1 shared Lixia ZengiD· 1 shared Pradeep P. KayampillyiD· 1 shared Subramaniam PennathuriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Ahmed Abdel‐LatifORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Sotagliflozin Reprograms Hepatic Lipid Metabolism and Attenuates Atherosclerosis Beyond Empagliflozin in CKM Mice

Keith Louis Saum, Jessica Sim, Lixia Zeng, Charles A. Steward, Pradeep P. Kayampilly, Alethia Dixon, Anand Singh, Ahmed Abdel‐Latif, Subramaniam Pennathur

This study compares sotagliflozin and empagliflozin in CKM mice, finding sotagliflozin more effectively reduces atherosclerosis and metabolic syndrome through hepatic lipid metabolism reprogramming.

bioRxiv · Oct 1, 2026 · PreprintPharmacology & Toxicology